BeiGene
BGNE
#984
Rank
$19.61 B
Marketcap
$175.87
Share price
-1.78%
Change (1 day)
-3.61%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeiGene (BGNE) - Cost to borrow shares

Latest borrow fee for BeiGene (BGNE) shares on Interactive Brokers: 0.2500% (annualized)

Shares available to borrow: 450000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

BeiGene (BGNE) - cost to borrow in the last 7 days chart

0.05 %0.1 %0.15 %0.2 %0.25 %0.3 %0companiesmarketcap.com

BeiGene (BGNE) - number of shares available to borrow in the last 7 days

100K200K300K400K500K0companiesmarketcap.com

BeiGene (BGNE) - cost to borrow from 2024 to 2023

20240.5 %1 %1.5 %0companiesmarketcap.com

BeiGene (BGNE) - number of shares available to borrow from 2024 to 2023

2024100K200K300K400K500K600K700K0companiesmarketcap.com

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
15.3779%0.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
2.12%0.25 M๐Ÿ‡บ๐Ÿ‡ธ USA